A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey

British Journal of Cancer

Volumn 76, Issue 3, 1997, Pages 401-405

  Thomas, H V ^a   Key, T J ^a   Allen, D S ^b   Moore, J W ^b   Dowsett, M ^c   Fentiman, I S ^d   Wang, D Y ^e  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Breast cancer; Oestradiol; Prospective study; Sex hormone binding globulin; Testosterone

Indexed keywords

ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; UNITED KINGDOM;

EID: 0030803940     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.398     Document Type: Article

References (25)

1. Adami HO, Johansson ED, Vegelius J and Viclor A (1979) Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Upsala J Med Sci 84: 259-274
2. Bernstein L, Ross RK, Pike MC, Brown JB and Henderson BE (1990) Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer 61: 298-302
3. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S and Secreto G (1996) Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88: 291-296
4. Blankenstein MA, Szymczak J, Daroszewski J, Milewicz A and Thijssen JH (1992) Estrogens in plasma and fatty tissue from breast cancer patients and women undergoing surgery for non-oncological reasons. Gynecol Endocrinol 6: 13-17
5. Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA and Schatzkin A (1996) Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 5: 533-539
6. Dowsett M, Goss PE, Powles TJ, Hutchinson G, Brodie AM, Jeffcoate SL and Coombes RC (1987) Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res 47: 1957-1961
7. Garland CF, Friedlander NJ, Barrett-Connor E and Khaw KT (1992) Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 135: 1220-1230
8. Grattarola R, Secreto G, Recchione C and Castellini W (1974) Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynecol 118: 173-178
9. Hammond GL, Langley MS and Robinson PA (1985) A liquid-phase immunoradiometric assay for human sex-hormone-binding-globulin. J Steroid Biochem 23: 451-460
10. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB and Comstock GW (1994) A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 18: 79-85
11. Henderson BE, Ross RK, Pike MC and Casagrande JT (1982) Endogenous hormones as a major factor in human cancer. Cancer Res 42: 3232-3239
12. Hill P, Garbaczewski L and Kasumi F (1985) Plasma testosterone and breast cancer. Eur J Cancer Clin Oncol 21: 1265-1266
13. Key TJA and Pike MC (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-43
14. Key TJA, Wang DY, Brown JB, Hermon C, Allen DS, Moore JW, Bulbrook RD, Fentiman IS and Pike MC (1996) A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 73: 1615-1619
15. McFadyen IJ, Forrest AP, Prescott RJ, Golder MP, Groom GV, Fahmy DR and Griffiths K (1976) Circulating hormone concentrations in women with breast cancer. Lancet i: 1100-1102
16. Moore JW, Clark GM, Hoare SA, Millis RR, Hayward JL, Quinlan MK, Wang DY and Bulbrook RD (1986) Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer 38: 625-630
17. Moore JW, Key TJ, Bulbrook RD, Clark GM, Allen DS, Wang DY and Pike MC (1987) Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Cancer 56: 661-666
18. Secreto G and Zumoff B (1994) Abnormal production of androgens in women with breast cancer. Anticancer Res 14: 2113-2117
19. Secreto G, Recchione C, Cavalleri A, Miraglia M and Dati V (1983) Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. Br J Cancer 47: 269-275
20. Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P Totis A, Fariselli G and Di Pietro S (1991) Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 51: 2572-2576
21. Siiteri PK, Hammond GL and Nisker JA (1981) Increased availability of serum estrogens in breast cancer: a new hypothesis. In Hormones and Breast Cancer. Pike MC, Siiteri PK and Welsch CW (eds), pp. 87-106. Cold Spring Harbor Laboratory: New York
22. The Anglo-Egyptian Health Agreement Collaborative Study (1988) Serum hormone levels in breast cancer patients and controls in Egypt and Great Britain. The Anglo-Egyptian Health Agreement Collaborative Study. Eur J Cancer Clin Oncol 24: 1329-1335
23. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P and Pasternack BS (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87: 190-197
24. Wysowski DK, Comstock GW, Helsing KJ and Lau HL (1987) Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 125: 791-799
25. Zaridze D, Kushlinskii N, Moore JW, Lifanova YE, Bassalyk L and Wang DY (1992) Endogenous plasma sex hormones in pre- and postmenopausal women with breast cancer: results from a case-control study in Moscow. Eur J Cancer Prev 1: 225-230